← Open Payments lookup

MICHAEL EVERSON: Open Payments

NPI 1356320287 · LEAWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$296 in 15 payments from 10 companies in 2025. Trend: 2023 $184 · 2024 $113 · 2025 $296

Food & beverage: $296
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.3$68
Neurocrine BioSciences, Inc.2$37
Lundbeck LLC2$37
Collegium Pharmaceutical, Inc.2$35
Bausch Health US, LLC1$25
E.R. Squibb & Sons, L.L.C.1$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$20
Almatica Pharma LLC1$20
Janssen Pharmaceuticals, Inc1$16
Axsome Therapeutics, Inc.1$15

Products named: REXULTI, ABILIFY ASIMTUFII, INGREZZA, Jornay PM, APLENZIN, COBENFY, CAPLYTA, LOREEV XR.

Industry payments across KS — which companies pay providers there.